Federal and state action needed to end the infectious complications of illicit drug use in the United States: IDSA and HIVMA's advocacy agenda

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


In response to the opioid crisis, IDSA and HIVMA established a working group to drive an evidence- and human rights-based response to illicit drug use and associated infectious diseases. Infectious diseases and HIV physicians have an opportunity to intervene, addressing both conditions. IDSA and HIVMA have developed a policy agenda highlighting evidence-based practices that need further dissemination. This paper reviews (1) programs most relevant to infectious diseases in the 2018 SUPPORT Act; (2) opportunities offered by the “End the HIV Epidemic” initiative; and (3) policy changes necessary to affect the trajectory of the opioid epidemic and associated infections. Issues addressed include leveraging harm reduction tools and improving integrated prevention and treatment services for the infectious diseases and substance use disorder care continuum. By strengthening collaborations between infectious diseases and addiction specialists, including increasing training in substance use disorder treatment among infectious diseases and addiction specialists, we can decrease morbidity and mortality associated with these overlapping epidemics.

Original languageEnglish
Pages (from-to)S230-S238
JournalJournal of Infectious Diseases
Issue numberSupplement_5
StatePublished - Oct 1 2020

Bibliographical note

Funding Information:
This work was supported by the National Institute on Drug Abuse, National Institutes of Health (grant number K02 DA032322 for career development to S. A. S.).

Publisher Copyright:
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.


  • Injection drug use
  • Medications for treatment of opioid use disorder
  • Opioid epidemic

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases


Dive into the research topics of 'Federal and state action needed to end the infectious complications of illicit drug use in the United States: IDSA and HIVMA's advocacy agenda'. Together they form a unique fingerprint.

Cite this